Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H4K3S | IM / RA |
Tdap given at 1041, symptoms of rash to chest started around 1050. 911 called. Epipen given. Oxygen applied. Patient began to be more sleepy, second dose of Epipen given. Patient was taken to outside hospital by EMS. From limited view of outside hospital medication records, patient required intubation at outside hospital related to reaction.
Annual physical exam Anaphylaxis, initial encounter POTS (postural orthostatic tachycardia syndrome) Idiopathic hypotension Moderate protein-calorie malnutrition (HCC) Short bowel syndrome with colon in continuity On total parenteral nutrition (TPN) Slow transit constipation Fibromyalgia Port-A-Cath in place Insomnia, unspecified type Anemia due to chronic illness Iron deficiency anemia secondary to inadequate dietary iron intake Chronic stridor Paradoxical vocal cord movement on respiration Vocal cord dysfunction Nasal septal perforation Seizure disorder (HCC) Urinary retention
acetaminophen 1,000 mg Per Feeding Tube Every 4 hours PRN bacitracin 500 Units/gram 1 application Topically 2 times daily, Apply to inside nose cyclobenzaprine HCl 10 mg Per G Tube 3 times daily PRN dimethicone 5 % Topically 2 times dai
Adhesives (itching, rash, blister), Benzocaine (anaphylaxis), Cefazolin (rash), Chlorhexidine (rash, blister), Compazine (anaphylaxis), Immune globulin (anaphylaxis), Iodinated Contrast Media (anaphylaxis), iron sucrose (anaphylaxis), lidocaine (hives, throat irritation), metoclopramide (anaphylaxis), morphine (hives), oxycodone (hives, rash, Headache, seizure), Pneumococcal vaccine (anaphylaxis), vancomycin (rash)
Pneumovax